Citius Oncology, Inc. Made Headway
Fri, Jun 20, 2025 at 07:19 PM
Citius Oncology, Inc. (CTOR:NASDAQ) shot up at $2.63, a gain of 69.7%. On Fri, Jun 20, 2025, CTOR:NASDAQ hit a New 2-Week High of $2.63. The stock appeared on our News Catalysts scanner on Mon, Jun 09, 2025 at 10:39 AM in the 'AGREEMENT' category. From Fri, Jun 06, 2025, the stock recorded 77.78% Up Days and 70.00% Green Days
The stock spiked on Fri, Jun 20, 2025 at $3.43 with a volume of 20M+.
About Citius Oncology, Inc. (CTOR:NASDAQ)
Citius Oncology will serve as a platform to develop and commercialize novel targeted oncology therapies.
Top 10 Gainers:
- Next Technology Holding Inc. (NXTT:NASDAQ), 158.65%
- Citius Oncology, Inc. (CTOR:NASDAQ), 69.68%
- System1, Inc. (SST:NYSE), 55.79%
- Innovative Eyewear, Inc. (LUCY:NASDAQ), 54.82%
- Moving iMage Technologies, Inc. (MITQ:NYSEMKT), 53.68%
- Lucas GC Limited (LGCL:NASDAQ), 51.58%
- Pixelworks, Inc. (PXLW:NASDAQ), 42.35%
- INLIF Limited (INLF:NASDAQ), 41.77%
- Anbio Biotechnology (NNNN:NASDAQ), 39.27%
- VolitionRx Limited (VNRX:NYSEMKT), 37.07%